Letras-Luna D, Rosas-Murrieta N, Pazos-Salazar N, Flores-Hernandez J, Castelan F, Venegas B
Int J Endocrinol. 2024; 2024:1634072.
PMID: 39669379
PMC: 11637629.
DOI: 10.1155/ije/1634072.
Berkovitz-Shperling R, Samara N, Meir R, Dominsky O, Azam F, Feferkorn I
Arch Gynecol Obstet. 2024; 310(5):2297-2304.
PMID: 39302412
PMC: 11485447.
DOI: 10.1007/s00404-024-07740-7.
Forgiarini A, Contreras M, Bonta S, Maggi S, Espinel L
Clin Exp Reprod Med. 2024; 52(1):101-105.
PMID: 39039638
PMC: 11900659.
DOI: 10.5653/cerm.2024.06884.
Ingold C, Navarro P, de Oliveira R, Barbosa C, Bedoschi G
Ther Adv Reprod Health. 2023; 17:26334941231196545.
PMID: 37674690
PMC: 10478554.
DOI: 10.1177/26334941231196545.
Iorio G, Rovetto M, Conforti A, Carbone L, Vallone R, Cariati F
Front Reprod Health. 2022; 3:704153.
PMID: 36303992
PMC: 9580822.
DOI: 10.3389/frph.2021.704153.
The Reproductive Functions of the Human Brain Regions: A Systematic Review.
Okafor I, Okpara U, Ibeabuchi K
J Hum Reprod Sci. 2022; 15(2):102-111.
PMID: 35928473
PMC: 9345277.
DOI: 10.4103/jhrs.jhrs_18_22.
Algorithm-based individualization methodology of the starting gonadotropin dose in IVF/ICSI and the freeze-all strategy prevent OHSS equally in normal responders: a systematic review and network meta-analysis of the evidence.
Marino A, Gullo S, Sammartano F, Volpes A, Allegra A
J Assist Reprod Genet. 2022; 39(7):1583-1601.
PMID: 35551563
PMC: 9365921.
DOI: 10.1007/s10815-022-02503-2.
A mathematical model for predicting the number of transferable blastocysts in next-generation sequencing-based preimplantation genetic testing.
Cai Y, Ding M, Zhang Y, Sun Y, Lin F, Diao Z
Arch Gynecol Obstet. 2021; 305(1):241-249.
PMID: 34218301
DOI: 10.1007/s00404-021-06050-6.
Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?.
Rubenfeld E, Dahan M
Obstet Gynecol Sci. 2021; 64(4):345-352.
PMID: 34102744
PMC: 8290150.
DOI: 10.5468/ogs.21067.
Severe ovarian hyperstimulation syndrome associated with long-acting GnRH agonist in oncofertility patients.
Christ J, Herndon C, Yu B
J Assist Reprod Genet. 2021; 38(3):751-756.
PMID: 33471229
PMC: 7910346.
DOI: 10.1007/s10815-020-02051-7.
Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer.
Castillo J, Haahr T, Martinez-Moya M, Humaidan P
Ups J Med Sci. 2020; 125(2):131-137.
PMID: 32366146
PMC: 7721056.
DOI: 10.1080/03009734.2020.1736696.
Severe early-onset ovarian hyperstimulation syndrome with liver dysfunction in an IVF segmentation cycle.
Singh N, Dogra Y, Saini M, Govindarajan M
BMJ Case Rep. 2020; 13(1).
PMID: 31988058
PMC: 7035818.
DOI: 10.1136/bcr-2019-233379.
A Second Dose of GnRHa in Combination with Luteal GnRH Antagonist May Eliminate Ovarian Hyperstimulation Syndrome in Women with ≥30 Follicles Measuring ≥11 mm in Diameter on Trigger Day and/or Pre-trigger Peak Estradiol Exceeding 10 000 pg/mL.
Deng L, Li X, Ye D, Blockeel C, Zhou X, Chen S
Curr Med Sci. 2019; 39(2):278-284.
PMID: 31016522
DOI: 10.1007/s11596-019-2031-5.
Rare genetic variants potentially involved in ovarian hyperstimulation syndrome.
Stouffs K, Daelemans S, Santos-Ribeiro S, Seneca S, Gheldof A, Gurbuz A
J Assist Reprod Genet. 2018; 36(3):491-497.
PMID: 30483911
PMC: 6439123.
DOI: 10.1007/s10815-018-1372-5.
Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome.
Ho V, Pham T, Le A, Ho T, Vuong L
J Ovarian Res. 2018; 11(1):70.
PMID: 30149808
PMC: 6112143.
DOI: 10.1186/s13048-018-0445-5.
Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.
Abbara A, Clarke S, Dhillo W
Endocr Rev. 2018; 39(5):593-628.
PMID: 29982525
PMC: 6173475.
DOI: 10.1210/er.2017-00236.
A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
Anaya Y, Mata D, Letourneau J, Cakmak H, Cedars M, Rosen M
J Assist Reprod Genet. 2017; 35(2):297-307.
PMID: 29086322
PMC: 5845042.
DOI: 10.1007/s10815-017-1074-4.
Gonadotropin-releasing hormone agonist triggering of oocyte maturation in assisted reproductive technology cycles.
Turkgeldi E, Turkgeldi L, Seyhan A, Ata B
Turk J Obstet Gynecol. 2017; 12(2):96-101.
PMID: 28913051
PMC: 5558384.
DOI: 10.4274/tjod.92979.
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.
Abbara A, Clarke S, Islam R, Prague J, Comninos A, Narayanaswamy S
Hum Reprod. 2017; 32(9):1915-1924.
PMID: 28854728
PMC: 5850304.
DOI: 10.1093/humrep/dex253.
What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study.
Tarlatzi T, Venetis C, Devreker F, Englert Y, Delbaere A
J Assist Reprod Genet. 2017; 34(10):1341-1351.
PMID: 28710674
PMC: 5633577.
DOI: 10.1007/s10815-017-0990-7.